Feline immunodeficiency virus (FIV) is a lentivirus isolated recently from domestic cats suffering from an immune deficiency syndrome (1) . FIV causes generalized lymphadenopathy and increased susceptibility to opportunistic infections, eventually culminating in death (2) (3) (4) (5) . We have characterized the molecular structure of FIV as a prelude to investigations of pathogenesis and development of both vaccine and drug therapies effective against lentivirus infections.
MATERIALS AND METHODS
Cells and Virus. The Petaluma strain of FIV was propagated in Crandall feline kidney cells (CRFK) and purified FIV was prepared from 48-hr harvests of tissue culture supernatants (1) . Virus-containing fractions were localized by assaying for the presence of Mg2"-dependent reverse transcriptase activity (1) . Viral RNA and cDNA Preparation. Virus-containing fractions were pooled and viral RNA was prepared as described (6) . cDNA was prepared from 500 ng of viral RNA by hybridizing an end-labeled random primer (7) . Specific activity (5 x 107 cpm per ,ug of DNA) was calculated as described (8) .
Genomic Libraries. DNA was prepared as described 49) from FIV-infected CRFK cells and partially digested with the restriction enzyme Sau3A to yield an average-sized fragment of 20 kilobases. Fragments were ligated into the BamHI site of the bacteriophage A vector, EMBL-4 (Stratagene), and six genomic equivalents of DNA were packaged and plated for subsequent screening using viral cDNA (see above). Positive clones were selected and taken through several cycles of purification prior to further analyses. Transfections. Full-length clone 34TF10 was transfected into CRFK cells by the calcium phosphate precipitation method (10) and culture supernatants were monitored for the appearance of Mg2"-dependent reverse transcriptase activity (1) .
Nucleotide Sequencing. Nucleotide sequencing was performed as described (11) . ll Specific proviral oligonucleotide primers were prepared to sequence the entire viral genome in both directions. The 5' end of the viral RNA was determined by sequencing viral RNA (12) primed by an oligonucleotide corresponding to the minus strand of a sequence unique to the U5 region of the viral long terminal repeat (LTR) (the complement of bases 292-316; see Fig. 2 ). RESULTS Transfection Studies. Clone 34TF10 was transfected into CRFK cells and the culture supernatant was monitored for Mg2+-dependent reverse transcriptase activity (Fig. 1) . Re Fig. 3 . well as feline peripheral blood lymphocytes (data not shown).
LTRs. The LTRs are 355 base pairs long and are bordered Nucleotide Sequence Analyses. Fig. 2 shows the nucleotide by 2-base-pair inverted repeats, (Fig. 2, underlined 5' LTR, bases 269-274, for continuity of discussion). These assignments dictate a U3 region of 215 base pairs, an R region of -75 base pairs, and U5 of =65 base pairs. In addition to the promoter signal (TATAA) at -26 and the polyadenylylation signal at +53, a sequence corresponding to a 9 of 11 match for the NF-K B enhancer element (16) is present in U3 (bases 50-60). The 5' LTR is immediately followed by the 18-base sequence corresponding to the tRNA-Lys primer binding site (bases 358-375; ref. 17) , similar to other lentiviruses thus far examined (18) (19) (20) (21) (22) (23) (24) (25) .
GAG Gene. The GAG gene of FIV (bases 627-1976) encodes a predicted polyprotein of450 amino acids (49,500 Da). The N-terminal protein, p15 ('14,900 Da), begins with the sequence Met-Gly-Asn-Gly, which should be compatible with myristoylation typical of the N-terminal lentivirus GAG protein of HIV-1 (26) . Two other proteins, p24 (-24,493 Da) and p1O (z9640 Da), that correspond to the major core protein and nucleic acid binding protein, respectively, are predicted to be encoded by the FIV GAG gene.
POL Gene. The POL gene (bases 1868-5239) overlaps the 3' end of the GAG gene. The POL polyprotein is presumably synthesized as a GAG-POL polyprotein by ribosomal frameshifting, similar to HIV-1 (27) . Two consensus sequences for frameshifting (28) are present in the overlapping region between GAG and POL (underlined), and the second precedes immediately the predicted N terminus of the protease protein (pr; ref. 29) . Alignment with the known N termini of HIV reverse transcriptase and endonuclease (14) predicts a protease of 13,493 Da and a reverse transcriptase of 61,490 Da.
In the primate lentiviruses, the endonuclease protein immediately follows reverse transcriptase in the polyprotein (14, (18) (19) (20) (21) (22) (23) . However, in the nonprimate lentiviruses including EIAV (24) and visna (25) as well as FIV ( Fig. 2 ; denoted by the symbol ?, bases 4013-4405) there are -400 base pairs intervening between reverse transcriptase and endonuclease when aligned with the primate POL genes (18) (19) (20) (21) (22) (23) . This region could thus encode a protein product of -14,600 Da. The 3' end of the polymerase gene is predicted to encode an endonuclease of 30,690 Da. Viral Infectivity Factor (VIF)? A third open reading frame overlaps the 3' end of the polymerase gene (Fig. 2, base 5199 ) and is preceded by a possible splice acceptor site (underlined). The location suggests that this region corresponds to the VIF of the primate viruses (18) (19) (20) (21) (22) (23) , although alignment with both primate lentiviruses and visna virus (25) yielded no significant similarity.
Intergenic Region. The region 3' to VIF has the potential to encode three short overlapping reading frames (Figs. 2 and 3 , A, B, and C) not found in other characterized lentiviruses (18) (19) (20) (21) (22) (23) (24) (25) 30) . This finding implies that either FIV differs in splicing strategy from the other lentiviruses or that this region of FIV has no coding capacity. Another possibility is that.the 34TF10 isolate contains changes in this region that close the reading frame (see below). Clearly, if the latter is true, the protein encoded by this region is not critical for viral replication or infectivity.
ENV Gene. The FIV envelope gene (Figs. 2 and 3 , ENV) overlaps the 3' end of open reading frame C. This designation Proc. Natl. Acad. Sci. USA 86 (1989) is shown in parentheses because there are =750 bases of coding capacity prior to the presumed hydrophobic leader sequence (encoded by bases 6710-6797, underlined) for ENV. It has recently been demonstrated that a portion of the region preceding the ENV leader of visna virus (25) is the first coding exon of a gene product (L; ref. 31 ) of unknown function. Possibly, a similar product is generated by FIV, although no sequence similarity is evident.
The amino acid sequence following the presumed ENV leader sequence contains 17 potential sites for N-linked glycosylation (brackets) prior to the predicted processing site for the minor glycoprotein at base 8096 (Arg-Arg-Lys-Arg, underlined). The minor glycoprotein (Fig. 2, tm) parsimonious phylogenetic tree, prepared at the nucleotide level using the first 420 amino acids of reverse transcriptase. This analysis indicates that FIV diverged early relative to the initial split between the primate and nonprimate lentiviruses. The percentage similarity of FIV to the other lentiviruses ranges from 41% to 45% within reverse transcriptase.
DISCUSSION
The results indicate that FIV shares many features with other lentiviruses. However, there is no molecular evidence to suggest that FIV came from another species recently. Clearly, FIV has the coding capacity for several possible protein species other than those encoded by GAG, POL, and ENV. It may be that the 34TF10 isolate contains mutations, particularly in the intergenic region between POL and ENV, resulting in three short open reading frames rather than one continuous reading frame. Preliminary analysis of another FIV isolate supports this contention in that the nucleotide sequence of the second isolate varies so as to encode one continuous gene product in the intergenic region between POL and ENV (unpublished data). Such mutations clearly do not interfere with viral replication, since the 34TF10 isolate is fully infectious. FIV will serve as a valuable small animal model for the study of lentivirus infection, etiology, and treatment.
